3 completed, 1 withdrawn. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Withdrawn 1 |
Follow Ginkgo biloba: new trials by email Literature Review of Ginkgo biloba trials Research Report on Ginkgo biloba
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of Steroid Therapy in Vestibular Neuritis Ginkgo biloba & Methylprednisolone, Ginkgo biloba - Vestibular Neuritis | Phase 3 | Completed | Asan Medical Center | 40 | 2014-03-01 | 2019-01-10 |
| EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer Ginkgo Biloba, Placebo - Breast Cancer, Neurotoxicity | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 226 | 2002-12-01 | 2016-07-06 |
| Ginkgo Biloba Prevention Trial in Older Individuals Ginkgo biloba, Placebo - Dementia, Alzheimer's Disease | Phase 3 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 3069 | 2000-10-01 | 2013-03-14 |
| Comparison of the Panax Ginseng + Associations to Ginkgo Biloba in the Treatment of Cognitive Function Disorders Panax Ginseng + Ginkgo Biloba + Polyminerals + Multivitamin, Ginkgo Biloba (Tebonin®) - Memory Deficit | Phase 3 | Withdrawn | EMS | 2021-02-24 |
Alzheimer Disease (1) · Breast Neoplasms (1) · Dementia (1) · Memory Disorders (1) · Neurotoxicity Syndromes (1) · Vertigo (1) · Vestibular Neuronitis (1)
Alliance for Clinical Trials in Oncology (1) · Asan Medical Center (1) · EMS (1) · National Center for Complementary and Integrative Health (NCCIH) (1)
United States (2) · Brazil (1) · South Korea (1)
Debra Barton, RN, PhD, AOCN, FAAN (1) · Hong Ju Park, Professor (1) · Steven T. DeKosky, M.D. (1)
PMID 19017911, PMID 20040554, PMID 20123670, PMID 28391531
U01AT000162 (1)